FKBPL and its peptide derivatives inhibit endocrine therapy resistant cancer stem cells and breast cancer metastasis by downregulating DLL4 and Notch4 von McClements, Lana, Annett, Stephanie, Yakkundi, Anita, O'Rourke, Martin, Valentine, Andrea, Moustafa, Nermeen, Alqudah, Abdelrahim, Simões, Bruno M, Furlong, Fiona, Short, Amy, McIntosh, Stuart A, McCarthy, Helen O, Clarke, Robert B, Robson, Tracy

Volltext

Phase III Study of Fluorouracil, Leucovorin, and Levamisole in High-Risk Stage II and III Colon Cancer: Final Report of Intergroup 0089 von HALLER, Daniel G, CATALANO, Paul J, MACDONALD, John S, O'ROURKE, Mark A, FRONTIERA, Michael S, JACKSON, Don V, MAYER, Robert J

Volltext

Vasoactivity of rucaparib, a PARP-1 inhibitor, is a complex process that involves myosin light chain kinase, P2 receptors, and PARP itself von McCrudden, Cian M, O'Rourke, Martin G, Cherry, Kim E, Yuen, Hiu-Fung, O'Rourke, Declan, Babur, Muhammad, Telfer, Brian A, Thomas, Huw D, Keane, Patrick, Nambirajan, Thiagarajan, Hagan, Chris, O'Sullivan, Joe M, Shaw, Chris, Williams, Kaye J, Curtin, Nicola J, Hirst, David G, Robson, Tracy

Volltext

Toward a Doctrine of Fair Use in Patent Law von O'Rourke, Maureen A.

Volltext

Abstract S5-07: SWOG S0500 – A randomized phase III trial to test the strategy of changing therapy versus maintaining therapy for metastatic breast cancer patients who have elevate... von Smerage, JB, Barlow, WE, Hayes, DF, Winer, EP, Leyland-Jones, B, Srkalovic, G, Tejwani, S, Schott, AF, O'Rourke, MA, Lew, DL, Gralow, JR, Livingston, RB, Hortobagyi, GN

Volltext

Shaping competition on the Internet: Who owns product and pricing information? von O'Rourke, Maureen A

Volltext

Multicenter Phase II Study to Evaluate a 28-Day Regimen of Oral Fluorouracil Plus Eniluracil in the Treatment of Patients With Previously Untreated Metastatic Colorectal Cancer von MANI, S, HOCHSTER, H, HOHNEKER, J, SCHILSKY, R. L, LOKICH, J, BECK, T, CHEVLEN, E. M, O'ROURKE, M. A, WEAVER, C. H, BELL, W. N, WHITE, R, MCGUIRT, C, LEVIN, J

Volltext

A Phase II Study of 9-Aminocamptothecin in Patients with Refractory Breast Cancer von Kraut, Eric H., Balcerzak, Stanley P., Young, Donn, O'Rourke, Mark A., Petrus, John J., Kuebler, J. Philip, Mayernik, David G.

Volltext

Tamoxifen versus high-dose oral medroxyprogesterone acetate as initial endocrine therapy for patients with metastatic breast cancer: a Piedmont Oncology Association study von Muss, H B, Case, L D, Atkins, J N, Bearden, 3rd, J D, Cooper, M R, Cruz, J M, Jackson, Jr, D V, O'Rourke, M A, Pavy, M D, Powell, B L

Volltext

Drawing the Boundary between Copyright and Contract: Copyright Preemption of Software License Terms von O'Rourke, Maureen A.

Volltext

Phase II trial to topotecan in hepatocellular carcinoma : A Southwest Oncology Group study von WALL, J. G, BENEDETTI, J. K, O'ROURKE, M. A, NATALE, R. B, MACDONALD, J. S

Volltext

Phase II evaluation of ifosfamide/mesna in metastatic prostate cancer. A Southwest Oncology Group study von Williamson, S K, Wolf, M K, Eisenberger, M A, O'Rourke, M A, Brannon, W, Crawford, E D

Volltext

Potentiation of opiate action in neuroblastoma N18TG2 cells by lipid incorporation von Law, P Y, Nicksic, T D, O'Rourke, MA, Koehler, JE, Herz, A, Loh, H H

Volltext

Circulating Glioma Cells Exhibit Stem Cell-like Properties von Liu, Tianrun, Xu, Haineng, Huang, Menggui, Ma, Wenjuan, Saxena, Deeksha, Lustig, Robert A, Alonso-Basanta, Michelle, Zhang, Zhenfeng, O'Rourke, Donald M, Zhang, Lin, Gong, Yanqing, Kao, Gary D, Dorsey, Jay F, Fan, Yi

Volltext

Lower Activation Energy for Catalytic Reactions through Host–Guest Cooperation within Metal–Organic Frameworks von Aguila, Briana, Sun, Qi, Wang, Xiaoliang, O'Rourke, Erica, Al‐Enizi, Abdullah M., Nafady, Ayman, Ma, Shengqian

Volltext

Epidermal Growth Factor Receptor Extracellular Domain Mutations in Glioblastoma Present Opportunities for Clinical Imaging and Therapeutic Development von Binder, Zev A., Thorne, Amy Haseley, Bakas, Spyridon, Wileyto, E. Paul, Bilello, Michel, Akbari, Hamed, Rathore, Saima, Ha, Sung Min, Zhang, Logan, Ferguson, Cole J., Dahiya, Sonika, Bi, Wenya Linda, Reardon, David A., Idbaih, Ahmed, Felsberg, Joerg, Hentschel, Bettina, Weller, Michael, Bagley, Stephen J., Morrissette, Jennifer J.D., Nasrallah, MacLean P., Ma, Jianhui, Zanca, Ciro, Scott, Andrew M., Orellana, Laura, Davatzikos, Christos, Furnari, Frank B., O'Rourke, Donald M.

Volltext

Vascular niche IL-6 induces alternative macrophage activation in glioblastoma through HIF-2α von Wang, Qirui, He, Zhenqiang, Huang, Menggui, Liu, Tianrun, Wang, Yanling, Xu, Haineng, Duan, Hao, Ma, Peihong, Zhang, Lin, Zamvil, Scott S., Hidalgo, Juan, Zhang, Zhenfeng, O’Rourke, Donald M., Dahmane, Nadia, Brem, Steven, Mou, Yonggao, Gong, Yanqing, Fan, Yi

Volltext

PDGF-mediated mesenchymal transformation renders endothelial resistance to anti-VEGF treatment in glioblastoma von Liu, Tianrun, Ma, Wenjuan, Xu, Haineng, Huang, Menggui, Zhang, Duo, He, Zhenqiang, Zhang, Lin, Brem, Steven, O’Rourke, Donald M., Gong, Yanqing, Mou, Yonggao, Zhang, Zhenfeng, Fan, Yi

Volltext

ATM‐CHK2‐Beclin 1 axis promotes autophagy to maintain ROS homeostasis under oxidative stress von Guo, Qi‐Qiang, Wang, Shan‐Shan, Zhang, Shan‐Shan, Xu, Hong‐De, Li, Xiao‐Man, Guan, Yi, Yi, Fei, Zhou, Ting‐Ting, Jiang, Bo, Bai, Ning, Ma, Meng‐Tao, Wang, Zhuo, Feng, Yan‐Ling, Guo, Wen‐Dong, Wu, Xuan, Zhao, Gui‐Feng, Fan, Guang‐Jian, Zhang, Sheng‐Ping, Wang, Chuan‐Gui, Cao, Long‐Yue, O'Rourke, Brian P, Liu, Shi‐Hui, Wang, Ping‐Yuan, Han, Shuai, Song, Xiao‐Yu, Cao, Liu

Volltext

Menogaril in the treatment of relapsed multiple myeloma. A phase II trial of the Cancer Center of Wake Forest University von Cruz, J M, Case, L D, Dalton, H B, Ramseur, W L, Richards, 2nd, F, Jackson, D V, Muss, H B, Zekan, P J, Brodkin, R A, Brown, R C

Volltext